First human test: scientists probe safety of new capsule
Knowledge-focused
Not yet recruiting
This is a first-in-human study to check the safety and see how the body absorbs and eliminates a new capsule called VV913. It will involve 56 healthy male volunteers who will receive a single dose of either the capsule or a placebo. The main goal is to understand how safe the cap…
Phase: PHASE1 • Sponsor: Vigonvita Life Sciences • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC